Biohub Leuven SRL
Ouverture de failliteBiohub Leuven reported total assets of €1.34m at the end of the 2023 financial year (annual accounts filed with the NBB on 15 Mar 2024).
The score of Biohub Leuven shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2023
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biohub Leuven's annual accounts
Filed annual accounts
- Year ended 30 Sep 2023filed on 15 Mar 2024
- Year ended 30 Sep 2022filed on 31 Mar 2023
Biohub Leuven's financial analysis
- Solvency-31.3%sector median: 52.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biohub Leuven
Biohub Leuven's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0758.747.955
- VAT number
- BE0758747955
- Peppol
- Registered · 0208:0758747955 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Nov 2020
- Registered office
- 3001 Leuven
- Latest accounts
- 2023 · filed on 15 Mar 2024
- Activity
- Regulation of and contribution to more efficient operation of businesses (NACE 84130)
Biohub Leuven (SRL) has been based in Leuven since 2020, active in: regulation of and contribution to more efficient operation of businesses. For 2023, it reports a net loss of 525,638 € and equity of −419,616 €; its revenue is not published. Its solvency stands at -31.3%, below the median of its sector (52.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biohub Leuven
Companies in the same business, of comparable size and area, outside its group.
- Kastor XI Regulation of and contribution to more efficient operation of businesses Oostkamp · balance sheet €1.10m
- Livinus Regulation of and contribution to more efficient operation of businesses Koksijde · balance sheet 812,474 €
- Sybefica Invest Regulation of and contribution to more efficient operation of businesses Knokke-Heist · balance sheet €2.60m
- Joos & C° Regulation of and contribution to more efficient operation of businesses Wetteren · balance sheet 666,975 €
- City Magazine Regulation of and contribution to more efficient operation of businesses Ostend · balance sheet 430,338 €
- Alphorion Regulation of and contribution to more efficient operation of businesses Etterbeek · balance sheet €1.80m
- Samenwerkingsverband Kordia Regulation of and contribution to more efficient operation of businesses Turnhout · balance sheet €2.32m
- Masters @ Solutions Regulation of and contribution to more efficient operation of businesses Ostend · balance sheet 255,453 €
Frequently asked questions about Biohub Leuven
What is the revenue of Biohub Leuven?
Biohub Leuven files its accounts in a format where revenue is optional: it is not published for 2023.
What is the VAT number of Biohub Leuven?
In Belgium, the VAT number is the company number prefixed with BE: BE0758747955 for Biohub Leuven, if the company is VAT-registered. Its company number (CBE) is 0758.747.955.
Where is the registered office of Biohub Leuven?
According to the CBE register, the registered office of Biohub Leuven is in 3001 Leuven.
What is the equity of Biohub Leuven?
At the close of the 2023 financial year, the equity of Biohub Leuven amounts to -419,616 €, a solvency of -31.3% of total assets.
Who manages Biohub Leuven?
The register lists 2 active mandates at Biohub Leuven. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biohub Leuven
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →